INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
63 hedge funds and large institutions have $36.6M invested in Infinity Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
86% less call options, than puts
Call options by funds: $9K | Put options by funds: $64K
Holders
63
Holding in Top 10
–
Calls
$9K
Puts
$64K
Top Buyers
| 1 | +$800K | |
| 2 | +$699K | |
| 3 | +$585K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$401K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$332K |
Top Sellers
| 1 | -$3.03M | |
| 2 | -$1.61M | |
| 3 | -$1.39M | |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$1.16M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$983K |